Larry Shadid
Psychiatry · Dallas, TXNPI 1346355484
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 364 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 10.6% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 364 payments — averaging $19.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$737
- Lundbeck LLC$612
- Takeda Pharmaceuticals U.S.A., Inc.$610
- Johnson & Johnson$575
- Bausch Health US, LLC$554
- AbbVie$538
- plus $3K from 19 others
What the payments were for
- Food & beverage$6,961100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 35 | $737 |
| Lundbeck LLC | 29 | $612 |
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $610 |
| Johnson & Johnson | 29 | $575 |
| Bausch Health US, LLC | 37 | $554 |
| AbbVie(2 entities) | 28 | $538 |
| Otsuka America Pharmaceutical, Inc. | 25 | $516 |
| Alkermes, Inc. | 26 | $505 |
| Neurocrine Biosciences, Inc. | 15 | $363 |
| Tris Pharma Inc | 15 | $297 |
| Supernus Pharmaceuticals, Inc. | 21 | $294 |
| Sunovion Pharmaceuticals Inc. | 15 | $192 |
| Shire North American Group Inc | 8 | $145 |
| Merck | 8 | $138 |
| Idorsia Pharmaceuticals US Inc | 8 | $137 |
| Vanda Pharmaceuticals Inc. | 5 | $136 |
| Corium, LLC | 5 | $122 |
| Ironshore Pharmaceuticals Inc. | 4 | $103 |
| Axsome Therapeutics, Inc. | 5 | $94 |
| Avanir Pharmaceuticals, Inc. | 4 | $77 |
| E.r. Squibb & Sons, L.L.C. | 3 | $67 |
| Neos Therapeutics, LP | 3 | $55 |
| Noven Therapeutics, LLC | 3 | $55 |
| Arbor Pharmaceuticals, Inc. | 2 | $23 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
How this compares
$6,961 in reported general payments places this provider in the 90th percentile of 2,238 psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyvanseLisdexamfetamine Dimesylate | 18 | $6,546 |
| Vilazodone Hcl | 22 | $1,798 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 30 | $1,168 |
| Zaleplon | 18 | $557 |
| Alprazolam | 66 | $290 |
| Trazodone Hcl | 39 | $281 |
| Sertraline Hcl | 19 | $258 |
| Zolpidem Tartrate | 32 | $174 |
| Lorazepam | 19 | $161 |
| Fluoxetine Hcl | 13 | $110 |
| Clonazepam | 25 | $92 |
| Bupropion XlBupropion Hcl | 11 | $58 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $610 | $6,54618 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,238 psychiatry providers in Texas.
Other psychiatry in Dallas
- Joel HolinerDallas$948K
- Augustus RushDallas$760K
- Darin OkudaDallas$402K
- Stephen VobachDallas$278K
- Carolyn RekerdresDallas$259K
- Madhukar TrivediDallas$209K
- Ella DalyDallas$67K
- Rakesh JainLake Jackson$7.2M
- Arvinder Pal WaliaAustin$2.5M
- Suresh SureddiPlano$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.